Patents by Inventor Lawrence Sherman

Lawrence Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200302820
    Abstract: Systems and methods implementing on-line learning including determining a concept from a set of stored concepts, the concept associated with a first explanation entry data matrix including a plurality of data fields populated with characteristics of a first explanation and the concept; associating a plurality of users with similar learning profiles based on a correlation metric with the first explanation entry; forming two test groups including a postulate explanation group and a hypothesis group; providing remote access to the first explanation to the postulate explanation group via a first plurality of client devices; delivering an assessment to both the postulate explanation group and hypothesis group; and comparing the results of the assessment outcomes to calculate a success metric indicating a relative strength of the first explanation compared to the second explanation and storing the success metric as part of the first explanation entry data matrix.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 24, 2020
    Inventor: Lawrence SHERMAN
  • Publication number: 20160296762
    Abstract: Examples of systems, apparatuses, and methods for classification of electrocardiogram signals during cardiopulmonary resuscitation are described. An example system may include a defibrillator comprising an electrocardiogram analyzer. The electrocardiogram analyzer may be configured to apply a prediction modeling technique to an electrocardiogram signal to generate a predicted signal. The electrocardiogram signal may be captured from a patient undergoing cardiopulmonary resuscitation. The electrocardiogram analyzer may be further configured to subtract the predicted signal from the electrocardiogram signal to generate an error signal and to classify a rhythm of the electrocardiogram signal as one of a shockable rhythm or non-shockable based on the error signal. Decision parameters derived from the signals may be used in conjunction with a machine learning technique to classify the electrocardiogram signal.
    Type: Application
    Filed: October 3, 2014
    Publication date: October 13, 2016
    Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
    Inventors: Alampallam R. Ramachandran, Lawrence Sherman, Jason Coult, Peter Kudenchuk, Allison Chin, Christopher Neils
  • Publication number: 20140057242
    Abstract: In general, in an aspect, embodiments of the invention can provide, a semi- or fully-automatic computer-implemented method for personalized electronic education of a student, the method including, performing a computerized assessment of the student, using a knowledge assessment module, to determine a knowledge deficit of the student associated with at least one concept, defining a learning profile for the student using a learning profile generation module, receiving, at a server module, a computerized explanation submission based on the learning profile, evaluating, using an explanation submission evaluation module of the server module, the received explanation submission based on an understanding of the concept by the student after presentation to the student of the explanation submission, and rating, using the explanation submission evaluation module, the explanation submission based on the evaluation.
    Type: Application
    Filed: August 27, 2012
    Publication date: February 27, 2014
    Applicant: GREAT EXPLANATIONS FOUNDATION
    Inventor: Lawrence SHERMAN
  • Publication number: 20100144965
    Abstract: In one aspect, embodiments disclosed herein relate to a process for curing a thermoset composition, including: reacting a curable composition comprising an epoxy resin, an epoxy-reactive compound, and a catalyst, wherein there is a stoichiometric excess of the epoxy resin; to form an intermediate product having unreacted epoxy groups and secondary hydroxyl groups; and etherifying at least a portion of the unreacted epoxy groups and the secondary hydroxyl groups, catalyzed by the catalyst, to form a thermoset composition.
    Type: Application
    Filed: April 22, 2008
    Publication date: June 10, 2010
    Inventors: Maurice Joel Marks, Courtney Lawrence Sherman
  • Publication number: 20050245974
    Abstract: A method of determining a state of ventricular fibrillation from a waveform, includes: performing calculations on the Fourier transform of the waveform voltage values by using the quotient of the power in a high frequency band and of the power in a low frequency band; and determining the state of ventricular fibrillation by relating this ratio to the state of ventricular fibrillation. A defibrillation system for use in treatment of ventricular fibrillation includes at least one sensor to measure heart rhythm and at least one applicator to apply a defibrillation shock to a patient. The system further includes at least one processor which is adapted to calculate the ratio and also to obtain user input regarding survival of subgroups and average response times in the user's domain which allows calculation of an estimated maximum overall survival and selection of an optimum threshold for the ratio measure based on this maximum.
    Type: Application
    Filed: December 27, 2004
    Publication date: November 3, 2005
    Inventor: Lawrence Sherman
  • Publication number: 20050245973
    Abstract: A method of determining a state of ventricular fibrillation from waveform obtained at sampling rates and with filtering typical of current clinical devices, includes: performing calculations to produce the autocorrelation function of the measured ventricular fibrillation heart rhythm over a given range of lags; determining a first value related to the sum of the absolute values of the series of values forming the autocorrelation function over the given range of lags over the period of time; and determining the state of ventricular fibrillation by relating the first value or the logarithm of the first value to the state of ventricular fibrillation. A defibrillation system for use in treatment of ventricular fibrillation includes at least one sensor to measure heart rhythm and at least one applicator to apply a defibrillation shock to a patient.
    Type: Application
    Filed: September 30, 2004
    Publication date: November 3, 2005
    Inventor: Lawrence Sherman
  • Publication number: 20050222951
    Abstract: Systems and methods of targeting savings deposits are provided that enable a depositor, such as a customer of a financial institution, to save money for various purposes or goals. A financial institution can make offers for targeting savings deposits to its customers using a financial statement that the financial institution prepares and provides to its customers to report information related to customers' financial accounts. Such offers can be solicited or unsolicited and can include one or more targeted savings plans customized to meet customers' savings goals. The financial statement can be further used to enable customers to enroll in one or more targeted savings plans and to make savings transactions according to such plans. A credit card account statement can be used for such purposes such that customers can make targeted savings deposits along with making payments to credit card accounts.
    Type: Application
    Filed: April 2, 2004
    Publication date: October 6, 2005
    Inventor: Lawrence Sherman
  • Patent number: 4841078
    Abstract: Bicyclic fused benzenoid compounds of the formula ##STR1## and pharmaceutically acceptable cationic and acid addition salts thereof, where M is O, CH.sub.2 or NR.sub.6 ; R.sub.6 is hydrogen, formyl, carbobenzyloxy or certain carboalkoxyalkyl, alkanoyl, alkyl, aralkyl or aralkylcarbonyl groups;A' is:(1) A where one of A and B is hydrogen such that when A is hydrogen, B is C(R.sub.2 R.sub.3)(CH.sub.2).sub.f Q and f is 1 or 2; when B is hydrogen, A is C(R.sub.2 R.sub.3)(CH.sub.2).sub.f Q and f is 0 or 1, when taken together A and OR.sub.1 form a lactone or certain derivatives thereof;(2) A' is ##STR2## (3) A' is Q.sub.3 ; Q is CO.sub.2 R.sub.7, COR.sub.8, C(OH)R.sub.8 R.sub.9, CN, CONR.sub.12 R.sub.13, CH.sub.2 NR.sub.12 R.sub.13, CH.sub.2 NHCOR.sub.14, CH.sub.2 NHSO.sub.2 R.sub.17 or 5-tetrazoyl;Q.sub.3 is ##STR3## 5-tetrazolyl, CH.sub.2 CONHCOR.sub.7, COOH or certain ester, amide, carboximido or sulfonimido derivatives thereof, CONHOH, CONHCONH.sub.2, or COCH.sub.2 Q.sub.4 where Q.sub.
    Type: Grant
    Filed: August 9, 1984
    Date of Patent: June 20, 1989
    Assignee: Pfizer Inc.
    Inventors: James F. Eggler, Michael R. Johnson, Lawrence Sherman
  • Patent number: 4118559
    Abstract: 9-Hydroxyhexahydrodibenzo[b,d]pyrans, 1-substituted-9-hydroxyhexahydrodibenzo[b,d]pyrans wherein the substituent is hydrogen, methyl, hydroxymethyl, formyl, carboxy, carbamyl, amino, mono- and di-alkylamino, alkanoylamino, phenalkylsulfonamido or alkylsulfonamido, and the corresponding 9-ketones, all of which are useful as CNS agents, especially as analgesics and tranquilizers, intermediates therefor the processes for their preparation.
    Type: Grant
    Filed: June 7, 1977
    Date of Patent: October 3, 1978
    Assignee: Pfizer Inc.
    Inventors: Michael Ross Johnson, Lawrence Sherman Melvin, Jr.